Syngene's Q2 FY27 revenue fell 9% YoY despite a 13% quarterly rise
Syngene reported Q2 FY27 revenue up 13% quarter on quarter but down 9% year on year, with operating EBITDA margin at 18%.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to TradingView, Syngene's revenue from operations in Q2 FY27 rose 13% from the previous quarter but dropped 9% compared with a year earlier. The operating EBITDA margin came in at 18%.
The presentation pointed to Bayview's first manufacturing agreement, expanded translational capabilities and progress on a global integrated platform. The source notes that the text is an AI-generated summary, so key figures should be checked against the original filing.
why it matters
A sequential gain alongside a yearly decline suggests uneven business momentum. Investors typically watch margins and whether new agreements can offset weakness seen a year earlier.
market impact
Shares of Syngene: mixed report, quarterly rise but yearly decline
tags
instruments
sources
- SYNGENE: Q2 revenue fell 9% YoY as the integrated platform expanded and Bayview secured its first agreement — TradingView, 27 October 2026 at 16:02 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗